Financials Babylon Holdings Limited

Equities

BBLN.F

JE00BQWMWC12

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 03:20:40 2024-04-12 pm EDT 5-day change 1st Jan Change
0.000001 USD -99.50% Intraday chart for Babylon Holdings Limited 0.00% 0.00%

Valuation

Fiscal Period: December 2021 2022
Capitalization 1 2,391 167.4
Enterprise Value (EV) 1 2,311 421.1
P/E ratio -4.29 x -0.56 x
Yield - -
Capitalization / Revenue 7.4 x 0.15 x
EV / Revenue 7.16 x 0.38 x
EV / EBITDA -9.51 x -1.43 x
EV / FCF -30,759,226 x -1,395,646 x
FCF Yield -0% -0%
Price to Book 14.6 x -0.66 x
Nbr of stocks (in thousands) 16,406 24,805
Reference price 2 145.8 6.750
Announcement Date 3/30/22 3/16/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022
Net sales 1 16.03 79.27 322.9 1,110
EBITDA 1 -162.2 -167.2 -243.1 -294.3
EBIT 1 -162.8 -169.1 -252.8 -305.7
Operating Margin -1,015.47% -213.28% -78.3% -27.55%
Earnings before Tax (EBT) 1 -145.8 -183.4 -376 -221.5
Net income 1 -140.3 -186.8 -368.5 -221.4
Net margin -874.93% -235.64% -114.11% -19.96%
EPS 2 -4.381 -5.809 -33.95 -12.01
Free Cash Flow - -121.9 -75.14 -301.8
FCF margin - -153.77% -23.27% -27.19%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 8/27/21 8/27/21 3/30/22 3/16/23
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales 1 119.7 266.4 265.4 288.9 289 311.1
EBITDA 1 -72.52 -72.24 -68.68 -54.3 -48.88 -45.78
EBIT 1 -112.7 -90.1 -148.3 -77.27 -96.73 -54.4
Operating Margin -94.19% -33.82% -55.87% -26.75% -33.47% -17.48%
Earnings before Tax (EBT) 1 -231.8 -91.35 -156.9 -89.61 -100.7 -63.24
Net income 1 -228.3 -91.36 -157.1 -89.89 -100.1 -63.23
Net margin -190.77% -34.29% -59.19% -31.12% -34.65% -20.32%
EPS 2 -16.25 -6.000 -10.25 -5.750 -4.500 -2.530
Dividend per Share - - - - - -
Announcement Date 3/10/22 5/12/22 8/9/22 11/10/22 3/9/23 5/10/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022
Net Debt 1 - - - 254
Net Cash position 1 211 26.9 80 -
Leverage (Debt/EBITDA) - - - -0.862 x
Free Cash Flow - -122 -75.1 -302
ROE (net income / shareholders' equity) - -169% -351% 106%
ROA (Net income/ Total Assets) - -40.1% -39.8% -55.2%
Assets 1 - 466.4 925.1 401.4
Book Value Per Share 2 5.430 1.550 9.990 -10.30
Cash Flow per Share 2 6.710 3.180 15.90 1.750
Capex 1 1.92 0.72 8.1 8.51
Capex / Sales 11.94% 0.91% 2.51% 0.77%
Announcement Date 8/27/21 8/27/21 3/30/22 3/16/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. BBLN.F Stock
  4. Financials Babylon Holdings Limited